AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 137.1 SEK 0.22%
Market Cap: 16.7B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AddLife AB
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Additional Paid In Capital
kr2.6B
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Additional Paid In Capital
kr7.6B
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Additional Paid In Capital
kr2.3B
CAGR 3-Years
230%
CAGR 5-Years
109%
CAGR 10-Years
85%
G
Genovis AB
STO:GENO
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Additional Paid In Capital
kr118m
CAGR 3-Years
6%
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

AddLife AB
Glance View

Market Cap
16.7B SEK
Industry
Life Sciences Tools & Services

AddLife AB, a prominent player in the life sciences sector, intricately weaves its narrative through a commitment to enhancing healthcare and laboratory services across Europe. Founded in Sweden, the company has established itself as a crucial intermediary, effectively bridging the gap between manufacturers of medical devices and the healthcare institutions that require them. AddLife operates by acquiring and developing niche companies within two core segments: Labtech and Medtech. Through Labtech, it supplies essential equipment, instruments, and consumables for diagnostic and research laboratories. In Medtech, it provides a variety of healthcare logistics, medical products, and services to hospitals and care facilities, enhancing their operational efficiencies. The financial heartbeat of AddLife rests on its adeptness at creating value through strategic acquisitions and organic growth, capitalizing on the increasing demand for innovative healthcare solutions. By continuously expanding its product portfolio and enhancing the capabilities of its subsidiaries, AddLife ensures a diversified revenue stream, mitigating risks associated with dependence on any single product or market. This approach not only fortifies their market position but also fuels their profit margins, as they deftly respond to shifting industry demands and regulatory changes. The company's shared values and decentralized business model promote entrepreneurship within its subsidiaries, fostering an environment where innovation can thrive—ensuring their continued success and substantial contribution to the evolving landscape of healthcare.

ALIF B Intrinsic Value
158.15 SEK
Undervaluation 13%
Intrinsic Value
Price

See Also

What is AddLife AB's Additional Paid In Capital?
Additional Paid In Capital
2.6B SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Additional Paid In Capital amounts to 2.6B SEK.

What is AddLife AB's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
33%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for AddLife AB have been 33% over the past three years .

Back to Top